Find verified Amiodarone Hydrochloride API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Amiodarone Hydrochloride for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Amiodarone Hydrochloride API.
Alternate Names: Nexterone, Trangorex, Amiodar
CAS No: 19774-82-4
Mol Formula: C25H30ClI2NO3
Mol Weight: 681.8 g/mol
IUPAC Name: (2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5- iiodophenyl]methanone;hydrochloride - Show More
API Description: Amiodarone Hydrochloride can cause developmental toxicity, female reproductive toxicity and male reproductive toxicity according to state or federal government labeling requirements. Amiodarone Hydrochloride is the hydrochloride salt of an iodine-rich benzofuran derivative with antiarrhythmic and vasodilatory activities. As a class III antiarrhythmic agent, amiodarone blocks the myocardial calcium, potassium and sodium channels in cardiac tissue, resulting in prolongation of the cardiac action potential and refractory period. In addition, this agent inhibits alpha- and beta-adrenergic receptors, resulting in a reduction in sympathetic stimulation of the heart, a negative chronotropic effect, and a decrease in myocardial oxygen demands. Amiodarone may cause vasodilation by stimulation of the release of nitric oxide and cyclooxygenase-dependent relaxing endothelial factors.
Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondi herry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market...Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. - Show More
We are in the business of making high-quality drugs by unlocking the possibilities of science. Over the years, we have established strong relationships with leading global generic pharmaceutical companies that have helped us expand our product offerings and geographic reach. We w rk with 16 of the 20 largest generic companies globally.We are a research and development (R&D)-driven API manufacturer, focused on undertaking dedic...We are in the business of making high-quality drugs by unlocking the possibilities of science. Over the years, we have established strong relationships with leading global generic pharmaceutical companies that have helped us expand our product offerings and geographic reach. We work with 16 of the 20 largest generic companies globally.We are a research and development (R&D)-driven API manufacturer, focused on undertaking dedicated R&D in our existing products and in areas where we believe there is growth potential in the future. - Show More
Hainan Poly Pharm. Co., Ltd. (Poly Pharm, stock code: 300630), founded in 1992, is a high-tech enterprise specialized in the research and development, production, and sales of generic drugs and innovative drugs. It is one of the few domestic pharmaceutical formulation companies w th internationalization as its leading strategy. It produces antipyretic analgesics, injections, digestive drugs, and antibiotics, among others. The ...Hainan Poly Pharm. Co., Ltd. (Poly Pharm, stock code: 300630), founded in 1992, is a high-tech enterprise specialized in the research and development, production, and sales of generic drugs and innovative drugs. It is one of the few domestic pharmaceutical formulation companies with internationalization as its leading strategy. It produces antipyretic analgesics, injections, digestive drugs, and antibiotics, among others. The company products include azithromycin, ganciclovir sodium, levetiracetam, pantoprazole sodium, and eptifibatide. - Show More
Sanofi Chimie S.A. is a French pharmaceutical manufacturing company and a wholly owned subsidiary of Sanofi, one of the world’s leading healthcare organizations. Sanofi Chimie plays a pivotal role in Sanofi’s global supply chain, focusing on the production of Active Pharmaceu ical Ingredients (APIs) and intermediates essential for the company's extensive portfolio of medicines. - Show More
CTX is one of the youngest and fastest-growing Indian API and Intermediate manufacturing companies doing business in over 70 countries. In these five years, all my thoughts and actions have been to enhance the life of my organization by serving the pharmaceutical industry with co plete dedication. CTX is accredited with US FDA, EU GMP, PMDA Japan and COFEPRIS Mexico cGMP. The ultimate business strategy of CTX Life Sciences is ...CTX is one of the youngest and fastest-growing Indian API and Intermediate manufacturing companies doing business in over 70 countries. In these five years, all my thoughts and actions have been to enhance the life of my organization by serving the pharmaceutical industry with complete dedication. CTX is accredited with US FDA, EU GMP, PMDA Japan and COFEPRIS Mexico cGMP. The ultimate business strategy of CTX Life Sciences is “ to be a partner in the global pharmaceutical and chemical industries and continue to be a reliable and consistent supplier of APIs and Intermediates. - Show More
Delmar Chemicals Inc, now part of the Minafin Group and operating under the Minakem brand, is a Montreal-based fine chemical manufacturer specializing in the development and production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The comp ny is recognized for its custom cGMP synthesis capabilities and serves pharmaceutical and biotech clients worldwide. - Show More
Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years of API development and manufacturing expertise, a growing team of more than 1,200 experts and a str ng presence in the USA and Europe, we are tried and trusted across branded and generic API markets. We put all of our energy and experience into bein...Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years of API development and manufacturing expertise, a growing team of more than 1,200 experts and a strong presence in the USA and Europe, we are tried and trusted across branded and generic API markets. We put all of our energy and experience into being your partner of choice. We create value for customers through manufacturing excellence, reliable quality and innovative science. Our people are the experts that our customers enjoy working with. - Show More
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company headquartered in Tel Aviv, Israel. It is the largest generic drug manufacturer in the world and ranks as the 26th largest pharmaceutical company globally. Teva specializes in generic medicines, branded drugs, and active pharmaceutical ingredients (APIs). Its notable branded products include Austedo (for Huntington's disease and tardive dyskinesia) and Ajovy (for migraine prevention), among others. - Show More
Hegno is a high-tech company engaged in developing, manufacturing & marketing pharmaceutical and nutritional ingredients. Hegno persistently works towards the mission of “Better nutrition, better life” with passion, creativity and dedication. Headquartered in Shanghai, China, Hegno established three manufacturing sites in Inner Mongolia Province and Yangtze River Delta, which have over 60 years of experience in APIs manuf...Hegno is a high-tech company engaged in developing, manufacturing & marketing pharmaceutical and nutritional ingredients. Hegno persistently works towards the mission of “Better nutrition, better life” with passion, creativity and dedication. Headquartered in Shanghai, China, Hegno established three manufacturing sites in Inner Mongolia Province and Yangtze River Delta, which have over 60 years of experience in APIs manufacturing. While promoting our technical strength on bio-fermentation and chemical synthesis. - Show More
Emcure Pharmaceuticals Limited is a leading Indian multinational pharmaceutical company headquartered in Pune, Maharashtra. Established in 1981 by Satish Mehta, Emcure has evolved from a contract manufacturer to a global healthcare company with a strong presence across major ther peutic areas and international markets. - Show More
